(MSTY) YieldMax MSTR Option - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • • Derivative Income
MSTY: Stock, Bonds, Income
The YieldMax MSTR Option Income Strategy ETF, listed on NYSE ARCA under the ticker MSTY, is an actively managed exchange-traded fund designed to generate current income while providing investors with exposure to the share price of MicroStrategy Incorporated, albeit with a cap on potential investment gains. This approach allows investors to benefit from the potential upside of MSTR's stock while mitigating some of the downside risks. By maintaining an active management strategy, the fund's managers can continually assess and adjust the portfolio to optimize income generation and equity exposure.
One key aspect of the YieldMax MSTR Option Income Strategy ETF is its commitment to its investment strategy, regardless of market conditions. Unlike some other funds that may shift to defensive positions during periods of economic uncertainty or market volatility, MSTY will continue to pursue its core investment objectives. This means that the fund will not attempt to time the market or make significant changes to its portfolio in response to short-term market fluctuations, which can help reduce trading costs and minimize the impact of emotional decision-making. Instead, the fund will remain focused on its long-term goals, seeking to provide a steady stream of income while maintaining exposure to MSTR's common stock.
As a non-diversified fund, the YieldMax MSTR Option Income Strategy ETF is able to concentrate its investments in a smaller number of securities, including options and other derivative instruments related to MSTR. This focused approach can be beneficial for investors seeking targeted exposure to MicroStrategy's stock, as it allows the fund to maximize its potential returns and income generation. However, it's worth noting that non-diversified funds can be more volatile than diversified funds, as they are more heavily reliant on the performance of a single security or a smaller group of securities. The fund's category is Derivative Income, which reflects its use of options and other derivative instruments to generate income and manage risk.
Additional Sources for MSTY ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MSTY ETF Overview
Market Cap in USD | 1,619m |
Category | Derivative Income |
TER | 0.99% |
IPO / Inception | 2024-02-21 |
MSTY ETF Ratings
Growth 5y | 70.4% |
Fundamental | - |
Dividend | 53.6% |
Rel. Strength Industry | 1210 |
Analysts | - |
Fair Price Momentum | 53.01 USD |
Fair Price DCF | - |
MSTY Dividends
Dividend Yield 12m | 92.50% |
Yield on Cost 5y | 339.22% |
Annual Growth 5y | -100.00% |
Payout Consistency | 100.0% |
MSTY Growth Ratios
Growth Correlation 3m | 51.1% |
Growth Correlation 12m | 73.2% |
Growth Correlation 5y | 73.2% |
CAGR 5y | 266.56% |
CAGR/Mean DD 5y | 23.15 |
Sharpe Ratio 12m | 2.04 |
Alpha | 216.81 |
Beta | 2.06 |
Volatility | 76.99% |
Current Volume | 5707.7k |
Average Volume 20d | 4450.1k |
As of January 22, 2025, the stock is trading at USD 29.74 with a total of 5,707,700 shares traded.
Over the past week, the price has changed by +8.94%, over one month by +9.46%, over three months by +47.56% and over the past year by +266.56%.
Yes. Based on ValueRay Analyses, YieldMax MSTR Option (NYSE ARCA:MSTY) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 70.37 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MSTY as of January 2025 is 53.01. This means that MSTY is currently undervalued and has a potential upside of +78.24% (Margin of Safety).
YieldMax MSTR Option has no consensus analysts rating.
According to ValueRays Forecast Model, MSTY YieldMax MSTR Option will be worth about 61 in January 2026. The stock is currently trading at 29.74. This means that the stock has a potential upside of +105.14%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 61 | 105.1% |